메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective:Schizophrenia is a chronic disorder usually characterized by relapses alternating with periods of full or partial remission. To reduce relapse and rehospitalization rates, new long-acting injectable antipsychotics are needed. In addition, the most effective treatment is expected to include psychosocial intervention such as relapse prevention programs for patients with schizophrenia. Therefore, we examined whether combined therapy involving psychosocial intervention for relapse prevention (PIRP) and longacting injectable risperidone could reduce relapse and rehospitalization rates among outpatients with schizophrenia. Methods:We conducted a prospective study of 65 subjects with schizophrenia who participated in the PIRP program for 1 year. The PIRP program consisted of insight-gaining (psychoeducation on medication and symptoms), relapse prevention, screening for early signs for relapse, and crisis intervention. Outcome measures were efficacy as determined by the Brief Psychiatric Rating Scale (BPRS), Clinical Global Impressions (CGI), and Global Assessment of Functioning (GAF); relapse rate; and associative variables of relapse and medication compliance. Results:Repeated-measure analysis of variance (ANOVA) showed that the combined therapy significantly improved the scores for the BPRS (p<0.01), CGI (p<0.01), and GAF (p<0.01) by 6 and 12 months of the study, compared with baseline scores. Overall, the 2-year relapse rate of the combined-therapy subjects was 37.1%. Logistic regression analysis showed that medication compliance was a predictor of 2-year relapse (p=0.03). Multiple regression analysis also revealed that medication compliance was related to early treatment discontinuation (p=0.00) and 2-year relapse (p=0.00). Conclusion:These findings indicate that combined therapy can be effective in maintaining medication compliance and reducing BPRS scores, suggesting a role for combined therapy in maintaining medication compliance and reducing schizophrenia symptoms. Studies with larger sample sizes are needed to examine whether these results apply to the overall schizophrenic population.

목차

등록된 정보가 없습니다.

참고문헌 (20)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0